Prognostic value of NK and T-lymphocytes markers in operable non-small cell lung cancer (NSCLC).
Skrzypski M, Szymanowska-Narloch A, Jassem E, Marczyk M, Polanska J, Biernat W, Rzyman W, Maciejewska A, Pawlowski R, Jassem J. Prognostic value of NK and T-lymphocytes markers in operable non-small cell lung cancer (NSCLC). Journal Of Clinical Oncology 2017, 35: 11556-11556. DOI: 10.1200/jco.2017.35.15_suppl.11556.Peer-Reviewed Original ResearchNon-small cell lung cancerRelapsed non-small cell lung cancerDistant metastasis-free survivalNormal lung parenchymaPrognostic valueLung parenchymaOperable non-small cell lung cancerEarly-stage non-small cell lung cancerShorter distant metastasis-free survivalStage non-small cell lung cancerNK activation markersNSCLC histological typesExpression of CXCR3Immune-targeted therapiesEndothelin receptor type BIIIA NSCLC patientsMetastasis-free survivalNK cell markersCell lung cancerT lymphocyte markersNormal lung tissuesPrimary resectionFree survivalNK cellsNSCLC patients